Ask about this product and your situation
For injected ingredients such as BPC-157, FDA records checked September 26, 2026 raise a concern that the body’s germ-fighting system may treat the substance as an invader. The FDA also points to unwanted material in the product and too little safety information from people.
The FDA cannot tell from the information it has whether BPC-157 would harm people who use it.
Ask what a reaction could look like for the exact medicine being offered and what help you would need.
The FDA’s concerns about these injected ingredients do not establish the same risk for every peptide or every form of medicine.
The FDA has not reviewed the safety, effects or quality of compounded medicines before marketing, as of September 26, 2026.
- Which unwanted effects have been found with this specific product?
- What is still uncertain?
- How do my other medicines or health conditions change the discussion?
- What would the plan be if a problem develops?
Pregnancy questions, if they apply to you
The labels for semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound) contain different pregnancy information; do not treat them as interchangeable.
If you are pregnant, might become pregnant or are breastfeeding, bring that up in the care discussion. Ask the clinician to explain the information for your actual medicine. If this does not apply to you, continue to the urgent symptoms below.
When the question is urgent
MedlinePlus warns that a severe allergic reaction may threaten life; it may become hard to breathe, or the tongue or face may swell.
MedlinePlus advises immediate emergency help for severe allergic symptoms: phone 911 or go at once to the nearest emergency room.
These symptoms need urgent attention; finding their cause requires a medical assessment.